Parkside Financial Bank & Trust’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Parkside Financial Bank & Trust’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-110	Closed	-$1.04K	–	2201
2023 Q3	$1.04K	Sell	110 -142	-56%	-$1.71K	﹤0.01%	1837
2023 Q2	$3.52K	Hold	252	–	–	﹤0.01%	1495
2023 Q1	$4.73K	Buy	252 +170	+207%	+$2.79K	﹤0.01%	1385
2022 Q4	$1.13K	Sell	82 -78	-49%	-$1.2K	﹤0.01%	1824
2022 Q3	$3K	Buy	160 +78	+95%	+$1.42K	﹤0.01%	1478
2022 Q2	$1K	Sell	82 -36	-31%	-$532	﹤0.01%	1786
2022 Q1	$2K	Buy	+118	New	+$2.4K	﹤0.01%	1668

Other funds holding CDMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Parkside Financial Bank & Trust's CDMO Position: Q4 2023 in Review

Parkside Financial Bank & Trust sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2023, closing a stake of 110 shares — an estimated $1.04K sold.

Parkside Financial Bank & Trust first reported a position in CDMO in Q1 2022 and held it in 7 quarters. The position peaked at $4.73K in Q1 2023. 175 funds tracked by Wall St. Rank hold CDMO as of Q4 2023.

Parkside Financial Bank & Trust reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Parkside Financial Bank & Trust sold 110 Avid Bioservices, Inc. Common Stock shares in Q4 2023, an estimated $1.04K.
Parkside Financial Bank & Trust first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2022 and held it in 7 quarters.
Parkside Financial Bank & Trust's Avid Bioservices, Inc. Common Stock position peaked at $4.73K in Q1 2023.
175 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2023.

Based on Parkside Financial Bank & Trust's 13F filing for Q4 2023, filed 1 Feb 2024.